Showing results (1401-1410 of 1,900) with videos related to

Sort By:
Pageof 190
Practical Radiation Oncology|January 10, 2015
Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case seriesHubert Y Pan, Shengpeng Jiang, Jordan Sutton, et al.
Cancer|September 28, 2020
Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016Karen J Wernli, Katherine A Callaway, Louise M Henderson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Influence of Geography on Prostate Cancer TreatmentChad Tang, Xiudong Lei, Grace L Smith, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
The Science of the Total Environment|March 1, 2023
Per- and polyfluoroalkyl substances fate and transport at a wastewater treatment plant with a collocated sewage sludge incineratorBrannon A Seay, Kavitha Dasu, Ian C MacGregor, et al.
Quality Management in Health Care|July 5, 2011
"Pay-for-performance" as a quality improvement tool: perceptions and policy recommendations of physicians and program leadersJ Frank Wharam, Matthew B Frank, Ann-Marie Rosland, et al.
The EMBO Journal|June 3, 2000
Three-dimensional cryo-electron microscopy localization of EF2 in the Saccharomyces cerevisiae 80S ribosome at 17.5 A resolutionM G Gomez-Lorenzo, C M Spahn, R K Agrawal, et al.
Brachytherapy|July 24, 2012
Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapyMichael J Zelefsky, Gil'ad N Cohen, Walter R Bosch, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2012
Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?Katherine O Castle, Karen E Hoffman, Lawrence B Levy, et al.
The Journal of Biological Chemistry|April 17, 2001
Demonstration of direct effects of growth hormone on neonatal cardiomyocytesC Lu, G Schwartzbauer, M A Sperling, et al.
Pageof 190